FRANCIS C POLI, the GC of $CNS, sold 5,000 shares of the company on 02-11-2026 for an estimated $330,000. We received data on the trade from a recent SEC filing. This was a sale of approximately 7.1% of their shares of this class of stock. Following this trade, they now own 65,675 shares of this class of $CNS stock.
$CNS Insider Trading Activity
$CNS insiders have traded $CNS stock on the open market 27 times in the past 6 months. Of those trades, 24 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $CNS stock by insiders over the last 6 months:
- ROBERT HAMILTON STEERS (Executive Chairman) has made 20 purchases buying 166,427 shares for an estimated $11,201,967 and 0 sales.
- MARTIN COHEN has made 4 purchases buying 100,000 shares for an estimated $5,982,411 and 0 sales.
- FRANCIS C POLI (GC, Secretary, EVP) has made 0 purchases and 3 sales selling 19,696 shares for an estimated $1,293,667.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CNS Hedge Fund Activity
We have seen 131 institutional investors add shares of $CNS stock to their portfolio, and 162 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CONGRESS ASSET MANAGEMENT CO removed 638,651 shares (-99.1%) from their portfolio in Q4 2025, for an estimated $40,094,509
- GOLDMAN SACHS GROUP INC added 526,096 shares (+215.6%) to their portfolio in Q4 2025, for an estimated $33,028,306
- CLEARBRIDGE INVESTMENTS, LLC removed 509,801 shares (-54.3%) from their portfolio in Q4 2025, for an estimated $32,005,306
- VICTORY CAPITAL MANAGEMENT INC removed 404,083 shares (-40.1%) from their portfolio in Q3 2025, for an estimated $26,511,885
- INVESCO LTD. removed 335,668 shares (-72.5%) from their portfolio in Q3 2025, for an estimated $22,023,177
- BOSTON TRUST WALDEN CORP removed 280,512 shares (-30.7%) from their portfolio in Q4 2025, for an estimated $17,610,543
- METLIFE INVESTMENT MANAGEMENT, LLC added 233,482 shares (+1424.3%) to their portfolio in Q3 2025, for an estimated $15,318,754
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CNS Revenue
$CNS had revenues of $143.8M in Q4 2025. This is an increase of 2.88% from the same period in the prior year.
You can track CNS financials on Quiver Quantitative's CNS stock page.
$CNS Congressional Stock Trading
Members of Congress have traded $CNS stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CNS stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CNS Analyst Ratings
Wall Street analysts have issued reports on $CNS in the last several months. We have seen 1 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 10/09/2025
- B of A Securities issued a "Underperform" rating on 10/02/2025
To track analyst ratings and price targets for $CNS, check out Quiver Quantitative's $CNS forecast page.
$CNS Price Targets
Multiple analysts have issued price targets for $CNS recently. We have seen 2 analysts offer price targets for $CNS in the last 6 months, with a median target of $72.5.
Here are some recent targets:
- John Dunn from Evercore ISI Group set a target price of $77.0 on 10/20/2025
- Craig Siegenthaler from B of A Securities set a target price of $68.0 on 10/02/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
